VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

BEXSERO
Vaccine Information
  • Vaccine Name: BEXSERO
  • Target Pathogen: Neisseria meningitidis
  • Target Disease: Meningitis
  • Product Name: Meningococcal Group B Vaccine
  • Tradename: BEXSERO
  • Manufacturer: Novartis Vaccines and Diagnostics, Inc
  • CDC CVX code: 163
  • Type: Subunit vaccine
  • Status: Licensed
  • Location Licensed: USA, Canada
  • Host Species for Licensed Use: Human
  • Allergen: Latex
  • Immunization Route: Intramuscular injection (i.m.)
  • Storage: Store at 2°C to 8°C (36°F to 46°F), do not freeze, and keep away from light.
  • Approved Age for Licensed Use: 10 to 25 years of age.
  • Description: BEXSERO (Meningococcal Group B Vaccine) is a sterile, white, opalescent, suspension for intramuscular injection. Each 0.5 mL dose of BEXSERO is formulated to contain 50 micrograms each of recombinant proteins Neisserial adhesin A (NadA), Neisserial Heparin Binding Antigen (NHBA), and factor H binding protein (fHbp), 25 micrograms of Outer Membrane Vesicles (OMV), 1.5 mg aluminum hydroxide (0.519 mg of Al3+), 3.125 mg sodium chloride, 0.776 mg histidine, and 10 mg sucrose at pH 6.4 – 6.7.(FDA: BEXSERO)
Host Response
References
FDA: BEXSERO: FDA: BEXSERO vaccine information [https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM431447.pdf]